Stocks / Miscellaneous · Office equipment
Diebold Nixdorf Incorporated Common stock DBD
Outside our quality screen, so we don’t track its dips. It’s 38% below its 52-week high.
Outside our quality screen. No fair value estimate for now: there isn’t enough data.
- Fair value est.
- n/a
- Market Value
- forming
- Off 52-wk high
- −38%
- Risk vs market
- Above marketbeta 1.10
52-week range 3% of the way from its 52-week low to its high
Price $56.05
4 bullish · 5 bearish See why
Repriced or dip?
Mixed signals
The price is 38% below its 52-week high (Jul 28), but the business held up: shares outstanding fewer shares, each owns more, revenue growth rate +1.9 pts, revenue +1.7%.
Some numbers held up (shares outstanding fewer shares, each owns more, revenue growth rate +1.9 pts, revenue +1.7%), others slipped (earnings per share −25.1%, net cash (cash minus debt) −9.7% of market cap since the high). The price is 38% below its 52-week high.
The price is 38% below its 52-week high, and the business changed too: earnings per share −25.1%, net cash (cash minus debt) −9.7% of market cap since the high.
Within 10% of its 52-week high, so there is no dip to judge yet.
The evidence 9 numbers, high vs now
- Revenue, last 12 months$3.9B → $3.9B (+1.7%)held up
- Revenue growth rate+4.3% → +6.2% a year (+1.9 pts)held up
- Earnings per share, 12 months$3.02 → $2.26 (−25.1%)changed
- Operating margin6.4% → 5.4% (−1.0 pts)about the same
- Shares outstanding−5.0% (fewer shares, each owns more)held up
- Net cash (cash minus debt)−9.7% of market cap since the highchanged
- Stock vs its sector (Miscellaneous)stock −38%, sector median 0% since Jul 28changed
- Price fall vs business numbersprice −38%, revenue/EPS/FCF median −12% (shown, not scored)
- Valuation multipleP/E 30.0× at the high → 24.8× now (shown, not scored)
Business numbers as reported at the high (12 months to Mar 31, 2026) vs the latest filing (12 months to Sep 30, 2026). Each measure is scored from −1 (business changed) to +1 (business intact) and weighted: revenue, earnings per share, free cash flow, operating margin, revenue growth rate, share count, net cash and the move vs its sector. 60 or more reads as a dip, 40 or less as a repricing. Analyst estimates are not in our data, so they are not used. How to read it
Data-based read, not advice.
Priced in
How much growth the market assumed at the 52-week high, the low and today (a reverse DCF).
52-wk high: P/E 30.0×; 52-wk low: P/E 24.8×; now: P/E 24.8×.
| High | Low | Now | |
|---|---|---|---|
| Price | $90.75Jul 28 | $55.05Oct 30 | $56.05 |
| Implied growth | n/a | n/a | n/a |
| P/E | 30.0× | 24.8× | 24.8× |
| EV/Sales | 1.0× | 0.7× | 0.7× |
What this means: a lower P/E than at the high means you pay less for each dollar of profit than buyers did then.
How it’s computed
Reverse DCF: the same 10-year free-cash-flow model as our fair value estimate (9.5% discount rate, growth for years 1–5 fading to 3% by year 10, 3% after), solved for the growth that makes it equal the market value at each price. For the high and the low we use only the filings that were public on that day, so nothing from a later report leaks back. Market value = that close × diluted shares. P/E = market value / 12-month net income; Price / FCF = market value / 12-month free cash flow; EV / Sales = (market value + debt − cash) / 12-month revenue. Hidden when the share count moved over 20% (split, merger), free cash flow is negative, or the company reports in another currency.
Valuation
What we estimate it's worth, and how it ranks on value vs every stock we cover.
Fair value estimate
No estimate for DBD: Capital spending isn't tagged for the latest period in SEC XBRL data. We’d rather show nothing than a made-up number.
Risk vs market
How risk vs market is measured
One year of daily returns (Oct 31 to Nov 2, 252 sessions). Beta = how much DBD moved for each 1% move in the S&P 500 (SPY); 1.0 moves with the market. Volatility is the yearly standard deviation of daily returns. Past behavior, not a forecast.
Swings more than the market, and its own price swings are 3.3× the S&P 500’s.
- Beta vs S&P 500
- 1.10
- Volatility
- 42% vs 13% SPY
- Correlation SPY
- 0.33
- Correlation QQQ
- 0.30
How it ranks
Where DBD stands vs every one of the 2,467 stocks we cover that has the number. Longer bar = better.
Top quarter on 1 of 4 measures
- Dividends + buybacks yield11% · cash paid out or used to retire shares, vs market capTop 5%of 2,227
- Revenue growth, last 12 months+6.2% · vs the 12 months beforeLowest 35%of 2,184
- Operating margin5.4% · of sales kept as operating profitLowest 31%of 1,549
- Return on invested capital8.3% · profit per dollar of capitalLowest 44%of 1,001
From SEC filings and our fair value estimate model. A ranking, not advice.
Valuation details
Fundamentals
The business itself: sales, profits, cash and debt, from SEC filings.
Bull vs bear
Rule-based from the data on this page, strongest first. Not advice.
Top bullish points 4 of 5
Cash returnsShare count down 6.5% in a year: $206M of buybacks over 12 months.
ValuationEV/EBITDA of 7.9×: modest for what the business earns before interest, tax and depreciation.
ValuationPrice / book of 2.0×, below the 3.1× median for the 12 Miscellaneous companies we cover.
Balance sheetDebt / equity of 1.0×, below the 1.2× median for the 9 Miscellaneous companies we cover.
Top bearish points 5 of 5
Balance sheetOperating income covers interest only 2.2× over the last 12 months.
Balance sheetNet debt of $764M, 40% of the market cap (Sep 30, 2026).
ProfitabilityReturn on equity is only 8% over the last 12 months.
ProfitabilityGross margin of 25%, below the 34% median for the 8 Miscellaneous companies we cover.
QualityDoesn’t pass our quality screen: no positive free cash flow.
All fundamentals
P/E 24.8 · ROE 8% · Sales +6%
Valuation
- P/E
- 24.8×Miscellaneous median 22.0×
- Price / FCF
- n/anot reported in its SEC filings
- FCF yield
- n/anot reported in its SEC filings
- EV / EBITDA
- 7.9×
- Price / sales
- 0.48×
- Price / book
- 2.03×
- Market cap
- $1.9Blisted
- Enterprise value
- $2.7B
Growth
- Revenue, 12 months
- $3.9B
- Sales growth, 12 months
- +6.2%vs the 12 months before
- Sales growth, 3 yrs
- +1.5%/yrfrom FY2024
- Diluted EPS, 12 months
- $2.11
- EPS growth, last FY
- n/afewer than two years of diluted EPS
- Net income, 12 months
- $77M
- Net income growth
- +52%12 months vs before
Profitability
- Gross margin
- 25.0%
- Operating margin
- 5.4%
- Net margin
- 2.0%
- FCF margin
- n/anot reported in its SEC filings
- Return on equity
- 8%
- Return on invested capital
- 8%
Balance sheet
- Cash & short-term inv.
- $185M
- Total debt
- $949M
- Net cash
- −$764M
- Debt / equity
- 1.01×
- Interest coverage
- 2.2×operating income / interest
Cash flow & returns
- Free cash flow, 12 months
- n/anot reported in its SEC filings
- FCF growth, 12 months
- n/anot reported in its SEC filings
- Dividend yield
- n/ano dividend payments tagged
- Payout ratio
- n/anot reported in its SEC filings
- Buybacks, 12 months
- $206M10.8% of market cap
- Share count, 1 year
- −6.5%diluted shares vs a year ago
- Stock-based comp
- $14M
Trailing 12 months to Sep 30, 2026; balance sheet at Sep 30, 2026. From Diebold Nixdorf Incorporated Common stock’s SEC filings. Sparklines show up to six fiscal years. n/a means we don’t hold that number, with the reason. How each is computed.
The business
Sales +5%
- Gross margin26%
- Operating margin9%
- Return on invested capital15%
- Return on equity8%
- Sales growth (latest quarter vs year-ago quarter)+5%
- Net debt / EBITDA2.1×
Chart & levels
Where the price is vs its key levels and trends.
Key levels
Every level vs today’s $56.05
- 52-wk lowlowest close, 1 year$55.05−1.8%
- PriceMon Nov 2 close$56.05you are here
- 52-wk highhighest close, 1 year$90.75+61.9%
Momentum & 52-week range
RSI 31 · 5 days −18.6%
Signals
Reversal signal setups, the public ledger and the next earnings date.
Setup & signals
No setup armed
No setup armed, so there’s no trigger or stop to track yet. Reversal signal rules only run on companies that pass our quality screen.
DBD is outside our quality screen
One text when a published rule fires on one of the 332 quality companies we track: the ticker, the price, the stop and a link to the numbers. Nothing else.
Voices & buzz
Who is talking about it, and how it compares with peers.
Who’s talking about it
Notable investors, executives, analysts and public figures on Diebold Nixdorf Incorporated Common stock in the last 48 hours. Headlines as published, each linked. Their words, not ours.
No notable mentions in the last 48 hours. Checked Nov 3, 5:14 PM ET.
Compare with peers
Closest in size in Office equipment
Information only, not investment advice. Fair value estimates and talking points are rule-based model output from public data and can be wrong; stop levels are reference points, not orders. How every number is computed.